EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium

Andrej Belancic iD, Josip Andelo Borovac iD

Journal of Cardiovascular Pharmacology and Therapeutics · 2026-08 · 31

DOI: 10.1177/10742484261476920 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 04.08.2026. Verfasst von Andrej Belancic und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Clinical Pharmacology and Toxicology & Faculty of Medicine, University of Rijeka, Rijeka, Croatia. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HypercholesterolemiaLDLPCSK9 inhibitorsadministrationantibodiesatherosclerosiscardiovascular diseasescholesterolhumanizedhypolipidemic agentsmonoclonaloralproprotein convertase 9

Autor:innen und Institutionen

  • Department of Basic and Clinical Pharmacology and Toxicology & Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
  • Department of Cardiovascular Diseases, University Hospital of Split (KBC Split), Split, Croatia.
  • Department of Pathophysiology, University of Split School of Medicine (MEFST), Split, Croatia.

ORCID-Profile: Andrej Belancic, Josip Andelo Borovac

Zitieren

APA

Belancic, A., & Borovac, J. A. (2026). From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium. Journal of Cardiovascular Pharmacology and Therapeutics, 31. https://doi.org/10.1177/10742484261476920

Vancouver

Belancic A, Borovac JA. From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium. Journal of Cardiovascular Pharmacology and Therapeutics. 2026;31. doi:10.1177/10742484261476920

BibTeX
@article{Belancic2026,
  author = {Belancic, Andrej and Borovac, Josip Andelo},
  title = {From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium},
  journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
  year = {2026},
  volume = {31},
  doi = {10.1177/10742484261476920}
}
Kostenlos starten →